Company Filing History:
Years Active: 2025
Title: Innovations of Chun-Wei Cheh in Hepatitis B Treatment
Introduction
Chun-Wei Cheh is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the treatment of viral infections. His innovative approach utilizes cyanobacterial biomass to address chronic hepatitis B virus (HBV) infections.
Latest Patents
Chun-Wei Cheh holds a patent for the "Use of cyanobacterial biomass in treating hepatitis B virus infection." This patent discloses the use of cyanobacterial biomass for treating HBV infection, specifically chronic HBV infection. The treatment, upon administration for at least one month, has been shown to significantly reduce the level of the surface antigen of hepatitis B virus (HBsAg) detectable in the subject receiving the treatment. Additionally, it mitigates insomnia associated with chronic HBV infection.
Career Highlights
Chun-Wei Cheh is associated with Far East Bio-tec Co., Ltd., where he continues to develop innovative solutions in the field of biotechnology. His work has garnered attention for its potential impact on public health, particularly in managing chronic viral infections.
Collaborations
Chun-Wei Cheh collaborates with talented individuals such as Chuang-Chun Chiuh and Yi-Hsiang Chen. Their combined expertise contributes to the advancement of research and development in their field.
Conclusion
Chun-Wei Cheh's innovative work in utilizing cyanobacterial biomass for treating hepatitis B virus infection represents a significant advancement in biotechnology. His contributions have the potential to improve the quality of life for individuals affected by chronic HBV infections.